Bloomberg News

Royalty Pharma Raises Elan Bid to $13.00 a Share as Well as CVR

June 07, 2013

Royalty Pharma raised its offer for Elan Corp Plc (ELN) to $13.00 a share plus a contingent value right of as much as $2.50 a share, the company said today.

The offer, previously at $12.50 per share, potentially values each Elan share at up to $15.50 if additional CVR payment events occur, according to the statement.

To contact the reporter on this story: Makiko Kitamura in London at mkitamura1@bloomberg.net

To contact the editor responsible for this story: Jacqueline Simmons at jackiem@bloomberg.net


China's Killer Profits
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus